• Call us now: 0300 303 0444
  • Call us now: 0300 303 0444

You are here

'Abnormal bleeding - indication of pre-womb cancer condition'

26 February, 2016

'Abnormal bleeding - indication of pre-womb cancer condition'

Women should be aware of the signs and symptoms of endometrial hyperplasia, states new national guidance.

Endometrial hyperplasia is a thickening of the lining of the womb, which is caused by overgrowth of the cells that line the womb and can develop into cancer.

The most common symptom of endometrial hyperplasia is abnormal vaginal bleeding.

This can include heavy menstrual bleeding, bleeding in between periods, irregular bleeding whilst on hormone replacement therapy (HRT) and bleeding after the menopause.

Risk factors include age, an increased BMI, polycystic ovarian syndrome, the use of tamoxifen as a treatment for breast cancer and the use of HRT for menopausal symptoms.

RCOG and the British Society for Gynaecological Endoscopy are behind the guidance.

At least 25,000 women in the UK are estimated to suffer from the condition, but many women aren’t aware of it.

Justin Clark, co-author of the guideline, said: ‘We hope the publication of this guideline help to raise awareness of the signs and symptoms which can be a precursor to womb cancer and our key message is that any woman experiencing abnormal bleeding or discharge, particularly after the menopause, should report this to their GP.

‘It may be nothing to worry about but it’s best to get it checked out.'

He added: ‘Endometrial hyperplasia is treatable and with early diagnosis, we can minimise the risks of developing womb cancer in the future.’

For more information and to read the full guideline, click here.

Printer-friendly version